RISK ASSESSMENT REPORT OF A NEW PSYCHOACTIVE SUBSTANCE: 4-METHYLMETHCATHINONE (MEPHEDRONE) IN ACCORDANCE WITH ARTICLE 6 OF COUNCIL DECISION 2005/387/JHA ON INFORMATION EXCHANGE, RISK ASSESSMENT AND CONTROL OF NEW PSYCHOACTIVE SUBSTANCES
Tallennettuna:
EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION, RISK ASSESSMENT REPORT OF A NEW PSYCHOACTIVE SUBSTANCE: 4-METHYLMETHCATHINONE (MEPHEDRONE) IN ACCORDANCE WITH ARTICLE 6 OF COUNCIL DECISION 2005/387/JHA ON INFORMATION EXCHANGE, RISK ASSESSMENT AND CONTROL OF NEW PSYCHOACTIVE SUBSTANCES. LISBOA, EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION, 2010, 16 p.
Ref.
174633
Sijainti:
SIIS rchivo
Palabras clave:
Detección, Drogodependencias, Efectos, Enfermedad, Estimulantes, Evaluación, Informes oficiales, Riesgo, Salud, Toxicidad, Unión Europea
Detección, Drogodependencias, Efectos, Enfermedad, Estimulantes, Evaluación, Informes oficiales, Riesgo, Salud, Toxicidad, Unión Europea
Samankaltaisia teoksia: RISK ASSESSMENT REPORT OF A NEW PSYCHOACTIVE SUBSTANCE: 4-METHYLMETHCATHINONE (MEPHEDRONE) IN ACCORDANCE WITH ARTICLE 6 OF COUNCIL DECISION 2005/387/JHA ON INFORMATION EXCHANGE, RISK ASSESSMENT AND CONTROL OF NEW PSYCHOACTIVE SUBSTANCES
- EUROPOL-EMCDDA JOINT REPORT ON A NEW PSYCHOACTIVE SUBSTANCE: 1-BENZYLPIPERAZINE (BZP). IN ACCORDANCE WITH ARTICLE 5 OF COUNCIL DECISION 2005/387/JHA ON INFORMATION EXCHANGE, RISK ASSESSMENT AND CONTROL OF NEW PSYCHOACTIVE SUBSTANCES
- Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances
- EMCDDA-Europol 2013 Annual Report on the implementation of Council Decision 2005/387/JHA. In accordance with Article 10 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances
- EMCDDA-Europol Joint Report on a new psychoactive substance: 5-(2-aminopropyl)indole. In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances
- Mephedrone: use, subjective effects and health risks
- RISK ASSESSMENT OF NEW PSYCHOACTIVE SUBSTANCES. OPERATING GUIDELINES